En_Línea. An Online Treatment to Change Lifestyle in Overweight and Obesity

October 11, 2019 updated by: Carmina Saldaña, University of Barcelona

En_Línea. An Online Treatment to Change Lifestyle in Overweight and Obesity: Study Protocol for a Randomized Controlled Trial

A randomized controlled trial to test the effectiveness of an online weight control program, called en_línea, comparing with a standard group therapy and a control group

Study Overview

Status

Unknown

Conditions

Detailed Description

This is a randomized controlled trial with three intervention arms: en_línea, standard group therapy and control group. To perform this study, 305 adults (18-65 years) with overweight type II (27-29.9 kg/m2) or obesity type I (30-34.9 kg/m2) will be invited to participate. Interventions will last 17 weeks with follow-ups 1, 3, 6 and 12 months after the post-treatment appointment. The primary outcome will be post-treatment weight loss and the maintenance during the follow-ups. Secondary outcomes will be adherence rates, drop outs and quality of life. Participants will be assessed before randomization and they will be sign an inform consent.

Study Type

Interventional

Enrollment (Anticipated)

305

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain, 08035
        • Recruiting
        • Unidad de Terapia de Conducta, University of Barcelona
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Overweight type II or obesity type I. BMI between 27 and 34.9 kg/m2
  2. Age between 18 and 65 years old
  3. Compliance with all evaluation phases.

Exclusion Criteria:

  1. Presence of several physical disease, i.e. diabetes, hypertension, cancer or metabolic disorders
  2. Presence of several psychological problem, i.e. depression, anxiety
  3. Presence of other eating disorders, i.e. anorexia nervosa, bulimia nervosa, binge eating disorders
  4. Use of drugs, i.e. slimming, anovulatory or psychotropic
  5. Pregnancy or planned pregnancy for the next six months
  6. Following another weight control program at the time of selection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Online intervention, en_línea
Participants will be provided with a username and a password to acess to a website. en_línea program is an online adaptation of the LEARN program. The five treatment areas are: Lifestyle, Exercise, Attitudes, Relationships and Nutrition. We have designed and developed a website (www.programaenlinea.org) with 17 weekly treatment sessions and an exclusive mobile application for self-recording.
This is an online adaptation of the LEARN program. A self-help weight control program developed by Kelly Brownell in 2004.
Other Names:
  • Web-based weight control program
Active Comparator: Standard group therapy
Participants in this arm will received a 10 sessions of standard primary care group therapy. Sessions 1 and 2 will be weekly and sessions from 3 to 10 will be biweekly. Sessions, between 8 and 10 participants, will be conducted by a specialized psychologist and they will last 90 minutes. Treatment areas will be the same as en_línea, beginning with nutrition and exercise and a progressive incorporation of the other topics. Material to work at home and self-recording will be provided in paper.
This is a traditional behavioral weight control program
No Intervention: Control group
Participants in the control group only will receive a biweekly newsletter by email without feedback. They will be provided with material and instructions to self-record their daily meals and exercise. The newsletter only will content basic information about nutrition and exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight loss
Time Frame: 4 months
5%-10% of weight loss respect the initial weight
4 months
Maintenance of weight loss 1 month follow-up
Time Frame: 1 month follow-up
Maintenance of weight loss
1 month follow-up
Maintenance of weight loss 3 months follow-up
Time Frame: 3 months follow-up
Maintenance of weight loss
3 months follow-up
Maintenance of weight loss 6 months follow-up
Time Frame: 6 months follow-up
Maintenance of weight loss
6 months follow-up
Maintenance of weight loss 12 months follow-up
Time Frame: 12 months follow-up
Maintenance of weight loss
12 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence
Time Frame: 4 months
80% of completed website activities and 80% of self-records
4 months
Drop out
Time Frame: 4 months
Percentage of participants who finish the treatment
4 months
Quality of life test measures
Time Frame: 4 months
Questionnaire of Quality of Life provided by the LEARN program
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2016

Primary Completion (Anticipated)

December 1, 2020

Study Completion (Anticipated)

December 1, 2020

Study Registration Dates

First Submitted

October 11, 2019

First Submitted That Met QC Criteria

October 11, 2019

First Posted (Actual)

October 15, 2019

Study Record Updates

Last Update Posted (Actual)

October 15, 2019

Last Update Submitted That Met QC Criteria

October 11, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • IRB00003099

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Research team have to meet and make a decision about this field

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Subscribe